How do thiazolidinedione medicines improve insulin sensitivity?
Thiazolidinediones, such as rosiglitazone and pioglitazone, improve insulin sensitivity by reducing the resistance of muscle and adipose (fat) cells to insulin and increasing the transport of glucose into these tissues.12
At the molecular level, these drugs function by activating PPARγ (peroxisome proliferator-activated receptor-gamma) receptors, which are primarily located in adipose tissue. Once activated, these receptors trigger the transcription of specific genes that regulate the metabolism of glucose and lipids. By modulating these metabolic pathways, the drugs enhance the body's ability to respond to insulin, thereby helping to lower blood glucose levels in patients with diabetes mellitus.21
While effective, these medications require careful clinical oversight due to potential side effects, which can include edema, adverse cardiovascular events, and liver toxicity.12